CLEVELAND, April 7, 2026 /PRNewswire/ -- Medistry LLC reports that early adopters of the premium .med top–level domain are helping define how AI systems classify medical organizations in an era where ...

The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.

NMPA's new BCI classification rules set device risk classes, a first regulatory gate for foreign investors in China neurotech.

Panelists discuss how current risk stratification systems, particularly the European Leukemia Net 2022 classification for intensive therapy and the 2024 classification for lower intensity treatments, ...